Company - Corporate Actions - Earnings
Kazia Therapeutics Limited (KZIA) confirmed earnings release on September 19, 2024, Before the market for the quarter ending June 30, 2024.
...
September 19, 2024 KZIA 8.40%
Galapagos NV (GLPG) confirmed earnings release on September 19, 2024, Before the market for the quarter ending June 30, 2024.The estimated EPS is $-0.16The annoucened EPS was $0.14The estimated revenue...
September 19, 2024 GLPG 0.30%
Can-Fite Biopharma Ltd (CANF) confirmed earnings release on September 19, 2024, Before the market for the quarter ending June 30, 2024.The estimated EPS is $-0.36The estimated revenue is $100000
...
September 19, 2024 CANF -8.37%
X.T.L. Biopharmaceuticals Ltd. (XTLB) confirmed earnings release on September 19, 2024, Before the market for the quarter ending June 30, 2024.
...
September 19, 2024 XTLB 2.25%
iHuman Inc (IH) confirmed earnings release on September 19, 2024, Before the market for the quarter ending June 30, 2024.The estimated revenue is $34604200
...
September 18, 2024 IH 0.90%
Boqii Holding Limited (BQ) confirmed earnings release on September 19, 2024, Before the market for the quarter ending June 30, 2024.The estimated revenue is $44260600
...
September 18, 2024 BQ -0.48%
Genfit (GNFT) confirmed earnings release on September 19, 2024, Before the market for the quarter ending June 30, 2024.
...
September 18, 2024 GNFT -3.12%
Galapagos NV (GLPG) confirmed earnings release on September 19, 2024, Before the market for the quarter ending June 30, 2024.The estimated EPS is $-0.16The estimated revenue is $70050000
...
September 18, 2024 GLPG 0.30%
Kazia Therapeutics Limited (KZIA) confirmed earnings release on September 19, 2024, Before the market for the quarter ending June 30, 2024.
...
September 18, 2024 KZIA 8.40%
Endava plc (DAVA) confirmed earnings release on September 19, 2024, Before the market for the quarter ending June 30, 2024.The estimated EPS is $0.29The estimated revenue is $258480000
...
September 18, 2024 DAVA -3.15%